Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/20410195

Download in:

View as

General Info

PMID
20410195